INAB (INAB) Stock Price & Analysis
INAB (INAB) rose 0.00% to USD 1.2 as of July 25, 2026 at 04:28 UTC, according to Nexqual real-time market data.
INAB last closed at USD 1.2; the session ranged USD 1.2–1.24 on volume of 29,742 shares. Market capitalization is —, with a 52-week range of USD 1.17–2.73 (NCM). Source: Nexqual, July 25, 2026 at 04:28 UTC.
Key Statistics (as of July 25, 2026 at 04:28 UTC)
| Price | USD 1.2 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 1.2 |
| Open | USD 1.2 |
| Day Range | USD 1.2 – 1.24 |
| 52-Week Range | USD 1.17 – 2.73 |
| Volume | 29,742 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (INAB)
Nexqual's technical model rates INAB "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:28 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 33.07 (neutral) |
| vs SMA50 | Below (USD 1.46) |
| MACD | -0.07 (negative) |
From INAB's Latest SEC 10-K Filing (filed 2026-03-12)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.55 | ▼ 7.74% |
| PXMD | PaxMedica, Inc. | USD 0 | ▲ 0% |
| SPRC | SciSparc Ltd. | USD 5.33 | ▲ 10.12% |
| DRMA | Dermata Therapeutics, Inc. | USD 1.32 | ▲ 4.76% |
| KPRX | Kiora Pharmaceuticals, Inc. | USD 2.55 | ▲ 0.79% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:28 UTC. This page is informational and not investment advice.